# Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes

> **NCT04636411** · PHASE3 · COMPLETED · sponsor: **Samar Fares, MD** · enrollment: 80 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Oral Magnesium Supplementation
- **OTHER:** Standard Care for diabetic patients

## Key facts

- **NCT ID:** NCT04636411
- **Lead sponsor:** Samar Fares, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636411, "Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04636411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*